BioCentury | Nov 15, 2019
Company News

Roche adds to fibrosis portfolio with $390M Promedior acquisition

...The biotech had raised $72.5 million across five venture financings from a syndicate that included Easton Capital Investment...
BioCentury | Mar 12, 2012
Financial News

Promedior completes venture financing

...$21.5 million Investors: Fibrotec Ventures; Morgenthaler Ventures; HealthCare Ventures; Polaris Venture Partners; Forbion Capital Partners; Easton Capital Investment WIR...
BioCentury | Jul 25, 2011
Emerging Company Profile

Resolve: Early answers, early exits

...partners: None Number of employees: 10 Funds raised: $2 million Investors: New Science Ventures and Easton Capital Investment...
BioCentury | May 23, 2011
Financial News

Resolve Therapeutics completes venture financing

...Business: Autoimmune Date completed: 5/17/11 Type: Venture financing Raised: $2 million Investors: New Science Ventures; Easton Capital Investment...
BioCentury | Apr 25, 2011
Finance

Third Deal on the Run

...$35 million B round. The firm joined existing investors TVM Capital, Forbion Capital Partners and Easton Capital Investment...
BioCentury | Apr 25, 2011
Financial News

bluebird bio completes venture financing

...Raised: $30 million Investors: Arch Venture Partners; Third Rock Ventures; TVM Capital; Forbion Capital Partners; Easton Capital Investment WIR...
BioCentury | Apr 21, 2011
Financial News

bluebird raises $30 million

...Arch Venture Partners joined existing investors Third Rock Ventures; TVM Capital; Forbion Capital Partners; and Easton Capital Investment...
BioCentury | Mar 22, 2010
Financial News

Promedior completes venture financing

...financing Raised: $12 million Investors: Forbion Capital Partners; Morgenthaler Ventures; HealthCare Ventures; Polaris Venture Partners; Easton Capital Investment WIR...
BioCentury | Mar 15, 2010
Financial News

Genetix completes venture financing

...financing Raised: $35 million Investors: Third Rock Ventures; Genzyme Ventures; TVM Capital; Forbion Capital Partners; Easton Capital Investment WIR...
BioCentury | Oct 16, 2006
Finance

Ebb & Flow

...their research on stem cells. Venture tracks Hans Mueller joined the scientific advisory board of Easton Capital Investment...
Items per page:
1 - 10 of 10
BioCentury | Nov 15, 2019
Company News

Roche adds to fibrosis portfolio with $390M Promedior acquisition

...The biotech had raised $72.5 million across five venture financings from a syndicate that included Easton Capital Investment...
BioCentury | Mar 12, 2012
Financial News

Promedior completes venture financing

...$21.5 million Investors: Fibrotec Ventures; Morgenthaler Ventures; HealthCare Ventures; Polaris Venture Partners; Forbion Capital Partners; Easton Capital Investment WIR...
BioCentury | Jul 25, 2011
Emerging Company Profile

Resolve: Early answers, early exits

...partners: None Number of employees: 10 Funds raised: $2 million Investors: New Science Ventures and Easton Capital Investment...
BioCentury | May 23, 2011
Financial News

Resolve Therapeutics completes venture financing

...Business: Autoimmune Date completed: 5/17/11 Type: Venture financing Raised: $2 million Investors: New Science Ventures; Easton Capital Investment...
BioCentury | Apr 25, 2011
Finance

Third Deal on the Run

...$35 million B round. The firm joined existing investors TVM Capital, Forbion Capital Partners and Easton Capital Investment...
BioCentury | Apr 25, 2011
Financial News

bluebird bio completes venture financing

...Raised: $30 million Investors: Arch Venture Partners; Third Rock Ventures; TVM Capital; Forbion Capital Partners; Easton Capital Investment WIR...
BioCentury | Apr 21, 2011
Financial News

bluebird raises $30 million

...Arch Venture Partners joined existing investors Third Rock Ventures; TVM Capital; Forbion Capital Partners; and Easton Capital Investment...
BioCentury | Mar 22, 2010
Financial News

Promedior completes venture financing

...financing Raised: $12 million Investors: Forbion Capital Partners; Morgenthaler Ventures; HealthCare Ventures; Polaris Venture Partners; Easton Capital Investment WIR...
BioCentury | Mar 15, 2010
Financial News

Genetix completes venture financing

...financing Raised: $35 million Investors: Third Rock Ventures; Genzyme Ventures; TVM Capital; Forbion Capital Partners; Easton Capital Investment WIR...
BioCentury | Oct 16, 2006
Finance

Ebb & Flow

...their research on stem cells. Venture tracks Hans Mueller joined the scientific advisory board of Easton Capital Investment...
Items per page:
1 - 10 of 10